A pathophysiological update of the incretins

GLP-1 agonists: an option for NAFLD?

Free Online Seminar: Advancements in oral insulin development

Oral insulin: The future of insulin therapy?

Can Remote Decentralised Clinical Trials enhance clinical research?

Can serious games motivate teenagers with diabetes to adhere to their treatment?

β3-adrenoceptor agonist Mirabegron – a candidate anti-obesity drug?

Once-weekly basal insulin analogue in clinical development

Glycaemic control in type 1 diabetes – effects of diabetes technology and socioeconomic status

The rollercoaster life of inhaled insulin